Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

TheMotleyFool's profile

Blog
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Arthur Tzianabos, the chair of Stoke Therapeutics (NASDAQ:STOK), disclosed the direct sale of 4,355 shares of Common Stock for a transaction value of approximately $174,000 on March 10, 2026

This F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/a8dc9bdd81bcb1d3921f5c802e4640087b0081c9-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
This F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround?

Celina J. Wang Doka, a director at F&G Annuities & Life (NYSE:FG), reported an open-market purchase of 4,760 shares for a weighted-average price of $20.98 per share, according to a SEC Form 4 filing

Should You Buy Lockheed Martin While It's Up 26% in 2026?: https://g.foolcdn.com/editorial/images/862123/us-air-force-fighter-jet.jpg
Should You Buy Lockheed Martin While It's Up 26% in 2026?

In a year marked by volatility and uncertainty, Lockheed Martin (NYSE: LMT) has been a bright spot in the market thus far. Shares of Lockheed are up over 26% in 2026, far outpacing the broader

Why Argan Stock Ascended Today: https://g.foolcdn.com/editorial/images/863250/construction-workers-building-at-sunset.jpg
Why Argan Stock Ascended Today

Shares of Argan (NYSE: AGX) spiked on Friday after the engineering company reported stronger-than-expected quarterly profits.

Image source: Getty Images.

With nearly two decades of experience in

LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know: https://cdn.content.foolcdn.com/images/1umn9qeh/production/1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know

Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular, reported the exercise and immediate sale of 2,625 shares of common stock for a transaction value of approximately $285,000 on March 11